Antiparasitic Treatment for Returning Travelers With Chronic Diarrhea

• Status: Unknown status
• Trial end date: 2016-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Study hypotheses is that Antiparasitic therapy in patients with chronic diarrhea after travel to a developing country, with a negative stool findings, will be significantly effective in eliminating diarrhea and other gastro-intestinal complaints compared to similar patients receiving placebo.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sheba Medical Center
• Treatments: Albendazole; Tinidazole

Criteria

Inclusion Criteria:

• Diarrhea (3 or more soft stools per day) for at least two weeks after a trip to a developing country in the past year

• Stool sample negative for bacteria, parasites and helminthes at least once

• Has not received, until now, antiparasitic or antihelminthic therapy

Exclusion Criteria:

• Bloody diarrhea

• Fever during enrolment 5. Allergy to the offered medication